Clinical Trial Update: Withdrawal of Inhaled Corticosteroids in Patients With COPD in Primary Care [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on withdrawing inhaled corticosteroids in patients with chronic obstructive pulmonary disease managed in primary care.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Inhaled corticosteroids (corticosteroid, inhaled)

Snippet

Sponsor: Queen Mary University of London | Conditions: Chronic Obstructive Pulmonary Disease | Phase 4 | Status: COMPLETED